000 | 01600 a2200493 4500 | ||
---|---|---|---|
005 | 20250518034335.0 | ||
264 | 0 | _c20200713 | |
008 | 202007s 0 0 eng d | ||
022 | _a1938-0666 | ||
024 | 7 |
_a10.1016/j.clbc.2019.02.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWernke, Karen | |
245 | 0 | 0 |
_aImpact of Implementing B-RST _h[electronic resource] |
260 |
_bClinical breast cancer _c08 2019 |
||
300 |
_ae547-e555 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBRCA1 Protein _xgenetics |
650 | 0 | 4 |
_aBRCA2 Protein _xgenetics |
650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
650 | 0 | 4 |
_aEarly Detection of Cancer _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGenetic Counseling _xmethods |
650 | 0 | 4 | _aGenetic Predisposition to Disease |
650 | 0 | 4 |
_aGenetic Testing _xmethods |
650 | 0 | 4 | _aHealth Plan Implementation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aOvarian Neoplasms _xdiagnosis |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aReferral and Consultation |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aSafety-net Providers _xstandards |
700 | 1 | _aBellcross, Cecelia | |
700 | 1 | _aGabram, Sheryl | |
700 | 1 | _aAli, Nadia | |
700 | 1 | _aStanislaw, Christine | |
773 | 0 |
_tClinical breast cancer _gvol. 19 _gno. 4 _gp. e547-e555 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clbc.2019.02.014 _zAvailable from publisher's website |
999 |
_c29608653 _d29608653 |